Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.

Nucl Med Commun

Department of aNuclear Medicine, University of Claude Bernard Lyon 1 bHematology, Hospices Civils de Lyon, Lyon cDepartment of Nuclear Medicine Hôpital Privé du Confluent, Nantes dDepartment of Nuclear Medicine eDepartment of Radiopharmacy, Grenoble University Hospital, Grenoble fDepartment of Nuclear Medicine, Centre Hospitalier Henri Mondor, Créteil, France gDepartment of Nuclear Medicine and Diagnostic Imaging Section, International Atomic Energy Agency, Vienna, Austria.

Published: July 2017

Fluorine-18-fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) is now a standard of care in initial staging and treatment evaluation of lymphomas. It is also used in the interim evaluation in diffuse large B cell lymphoma and Hodgkin lymphoma. However, several pitfalls may occur during or after treatment, because of the nonspecificity of F-FDG for lymphoma disease and treatment as immunotherapy, thus possibly induces misinterpretation and wrong treatment decision. The aim of this pictorial review is to provide an illustrated tutorial of the most frequent pitfalls found on F-FDG-PET/CT during or after treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000697DOI Listing

Publication Analysis

Top Keywords

pictorial review
8
treatment
6
usual unusual
4
unusual pitfalls
4
pitfalls 18f-fdg-pet/ct
4
lymphoma
4
18f-fdg-pet/ct lymphoma
4
lymphoma treatment
4
treatment pictorial
4
review fluorine-18-fluorodeoxyglucose
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!